Weight-Loss Drugs: Coverage Stalls as Demand Soars
Update: 2025-09-10
Description
Obesity Drug Dilemma: Cigna Reveals Stagnant Coverage Despite Surging Demand. Discover why employers are hesitant to pay for pricey weight-loss medications like Wegovy and Zepbound, even as employee usage skyrockets. With costs reaching $1000/month and employer concerns about ROI amidst high turnover, companies face tough choices balancing benefits and rising premiums. Learn how Cigna aims to ease the burden with capped out-of-pocket costs, potentially making these treatments more accessible.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
